Frost & Sullivan recognizes hc1.com with 2015 North American Award for Product Leadership

Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership. Since its inception in 2011, hc1.com has become the world's most widely connected healthcare relationship management platform in the diagnostic laboratory market. The company's Healthcare Relationship Cloud® platform is the only solution built from the ground up to meet the specific needs of healthcare organizations.

By automatically creating holistic provider and patient profiles that include all relevant business and clinical information, hc1 delivers unprecedented visibility across the healthcare spectrum—from health systems and laboratories to physicians and patients. Armed with live intelligence including physician test ordering patterns, test result timeliness, and the patients who require attention based on specific result values, labs are able to offer proactive, highly-targeted services that ultimately translate into strong retention of referring providers and an outstanding patient experience.

"hc1.com is unique in that its solution combines the capabilities of both healthcare-specific CRM and live business intelligence into a single platform," said Frost & Sullivan Research Analyst Divyaa Ravishankar. "As a result, the adoption of the hc1 Healthcare Relationship Cloud is spreading from data-rich labs to health systems, specialty hospitals, ambulatory service providers and post-acute care organizations seeking to compete in the new, value-based healthcare environment."

For instance, the hc1 Healthcare Relationship Cloud eliminated data silos and improved communication frameworks within Alere's toxicology business unit, which operates nine locations across the United States. With multiple lab information management platforms, billing systems and customer service centers, aggregating data to create a uniform client view proved to be a considerable challenge for Alere. Without having to replace existing systems, the hc1 platform unified data into a holistic view to enable a consistent client experience across all locations while providing the executives visibility into the health of key client relationships.

Another critical function for labs is gaining insight into payer test coverage patterns to optimize financial performance. Labs and health systems run the risk of losing money when tests are not covered by Medicare, Medicaid, or commercial insurance services. hc1's utilization insight solution is synced with the National Coverage Determination (NCD) database, which lists the tests falling within the scope of coverage and aids physicians in making informed decisions about which tests to order.

"Investing in the hc1 solution can also support labs with outreach activities," noted Ravishankar. "By tracking total test volume and number of tests run per patient, a lab can identify at-risk clients and set up campaigns for specific tests, thereby immediately making a positive impact on its business."

By combining healthcare CRM, real-time analytics and secure collaboration features, hc1 is able to meet the unique needs of the healthcare market. Further, its specialized support for diagnostic labs has led to its rapid ascent to the top of the diagnostic lab CRM market in North America.

Each year, Frost & Sullivan presents this award to the company that demonstrates innovation in product features and functionality that provides enhanced quality and higher value to customers. The award recognizes the rapid acceptance such innovation finds in the marketplace.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research.